 Home > Active Ingredient News > Digestive System Information > Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injection

Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injection

 Last Update: 2021-05-02
 Source: Internet
 Author: User

Tags

natural product database

acid reflux dehydration

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 19, Poinsettia issued an announcement stating that its wholly-owned subsidiary, Guangzhou Poinsettia Pharmaceutical Co.

Pantoprazole sodium for injection Indications: suitable for duodenal ulcer, gastric ulcer, moderate and severe reflux esophagitis, duodenal ulcer, gastric ulcer, acute gastric mucosal disease, compound gastric ulcer, etc.

Pantoprazole is a proton pump inhibitor (PPI), which inhibits the last step of gastric acid production by covalently binding to two sites in the H+-K+ATPase system of gastric parietal cells.

According to the PDB database of China Medical Information Center, sales in 2019 reached 1.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.